E-LIB Suche - Ergebnisse für: Ohanian, Maro

1

A phase 1/2 study of mini-hyper-CVD plus venetoclax in pati..:

Short, Nicholas J. ; Jabbour, Elias ; Jain, Nitin...
Blood Advances. 8 (2024) 4 - p. 909-915 , 2024

Link: https://doi.org/10.1182/..

2

KIT‐mutated pediatric core‐binding factor systemic mastocyt..:

Sheikh, Irtiza N. ; AlQahtani, Shaikha ; Yin, C. Cameron...
Pediatric Blood & Cancer. 71 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

3

Complex I inhibitor of oxidative phosphorylation in advance..:

Yap, Timothy A. ; Daver, Naval ; Mahendra, Mikhila...
Nature Medicine. , 2023

Link: https://doi.org/10.1038/..

4

A phase 1/2 study of azacitidine, venetoclax and pevonedist..:

Short, Nicholas J. ; Muftuoglu, Muharrem ; Ong, Faustine...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Response patterns and impact of MRD in patients with IDH1/2..:

Hammond, Danielle ; Loghavi, Sanam ; Wang, Sa A....
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Efficacy and safety of enasidenib and azacitidine combinati..:

Venugopal, Sangeetha ; Takahashi, Koichi ; Daver, Naval...
Blood Cancer Journal. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

7

Activity of decitabine as maintenance therapy in core bindi..:

Senapati, Jayastu ; Shoukier, Mahran ; Garcia‐Manero, Guillermo...
American Journal of Hematology. 97 (2022) 5 - p. 574-582 , 2022

Link: https://doi.org/10.1002/..

8

Hypomethylating agent and venetoclax with FLT3 inhibitor "t..:

Yilmaz, Musa ; Kantarjian, Hagop ; Short, Nicholas J....
Blood Cancer Journal. 12 (2022) 5 - p. , 2022

Link: https://doi.org/10.1038/..

9

Retrospective comparison of survival and responses to Fluda..:

Borthakur, Gautam ; Ravandi, Farhad ; Patel, Keyur...
American Journal of Hematology. 97 (2022) 11 - p. 1427-1434 , 2022

Link: https://doi.org/10.1002/..

10

Blinatumomab is associated with favorable outcomes in patie..:

Jabbour, Elias J. ; Short, Nicholas J. ; Jain, Nitin...
American Journal of Hematology. 97 (2022) 9 - p. 1135-1141 , 2022

Link: https://doi.org/10.1002/..

11

Hepatitis B virus reactivation in patients with past HBV in..:

Chiu, Chia-Yu ; Patel, Krina ; Thomas, Sheeba K....
Hepatology International. 17 (2022) 2 - p. 509-511 , 2022

Link: https://doi.org/10.1007/..

12

Nivolumab maintenance in high-risk acute myeloid leukemia p..:

Reville, Patrick K. ; Kantarjian, Hagop M. ; Ravandi, Farhad...
Blood Cancer Journal. 11 (2021) 3 - p. , 2021

Link: https://doi.org/10.1038/..

13

Outcomes of TP53‐mutant acute myeloid leukemia with decitab..:

Kim, Kunhwa ; Maiti, Abhishek ; Loghavi, Sanam...
Cancer. 127 (2021) 20 - p. 3772-3781 , 2021

Link: https://doi.org/10.1002/..

14

A phase I/II study of the combination of quizartinib with a..:

Swaminathan, Mahesh ; Kantarjian, Hagop M ; Levis, Mark...
Haematologica. 106 (2021) 8 - p. 2121-2130 , 2021

Link: https://doi.org/10.3324/..

15

Freeze‐dried platelets are a promising alternative in bleed..:

Ohanian, Maro ; Cancelas, Jose A. ; Davenport, Robertson...
American Journal of Hematology. 97 (2021) 3 - p. 256-266 , 2021

Link: https://doi.org/10.1002/..